NHI

National Health Investors Inc

$75.84 -0.28 (-0.37%) At close · Jul 15

Market Cap

$3.68B

48,471,079

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

Net shares bought

0.00%

Net buy value

+$167,027

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-06-15	MCCABE ROBERT A JR	Director, Chief Banking Officer	Buy↑	Shares Of Common Stock	890	$71.65	$63,767	44,158
2026-06-05	Mendelsohn D. Eric	Director, CEO and President	Buy↑	Common Stock	1,500	$68.84	$103,260	133,316
2026-06-05	Jobe James R	Director	Gift↓	Common Stock	225	—	—	33,272
2026-05-05	Mendelsohn D. Eric	Director, CEO and President	Tax↓ Filing footnotes — Common Stock (Direct) Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock on May 5, 2026.	Common Stock	394	$73.09	$28,797	131,816
2026-05-05	Travis David L	SVP/Chief Accounting Officer	Tax↓ Filing footnotes — Common Stock (Direct) Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock on May 5, 2026.	Common Stock	282	$73.09	$20,611	40,565
2026-05-05	Spaid John L	CFO/EVP Finance	Tax↓ Filing footnotes — Common Stock (Direct) Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock on May 5, 2026.	Common Stock	314	$73.09	$22,950	56,286
2026-03-03	Travis David L	SVP/Chief Accounting Officer	Tax↓ Filing footnotes — Common Stock (Direct) Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock on March 3, 2026.	Common Stock	411	$86.75	$35,654	40,847
2026-03-03	Mendelsohn D. Eric	Director, CEO and President	Award↑ Filing footnotes — Common Stock (Direct) Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to the reporting person's continued service through each vesting date.	Common Stock	14,409	—	—	132,807
2026-03-03	Jobe James R	Director	Award↑ Filing footnotes — Common Stock (Direct) Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.	Common Stock	1,268	—	—	1,268
2026-03-03	Todd Candice W	Director	Award↑ Filing footnotes — Common Stock (Direct) Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.	Common Stock	1,268	—	—	2,563
2026-03-03	Spaid John L	CFO/EVP Finance	Award↑ Filing footnotes — Common Stock (Direct) Due to an administrative error, the number of securities reported as awarded to the Reporting Person on March 3, 2026 was understated by 346 shares. This Form 4/A is being filed to report the correct number of securities awarded. Represents the total owned after all of the reporting person's transactions that occurred on 03/03/2026.	Common Stock	5,072	—	—	56,600
2026-03-03	Blankenship Elizabeth Jackson	SVP, Legal Affairs	Award↑ Filing footnotes — Common Stock (Direct) Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to the reporting person's continued service through each vesting date.	Common Stock	2,420	—	—	2,420
2026-03-03	COLDEN TRACY M J	Director	Award↑ Filing footnotes — Common Stock (Direct) Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.	Common Stock	1,268	—	—	12,858
2026-03-03	PASCOE KEVIN CARLTON	Chief Investment Officer	Award↑ Filing footnotes — Common Stock (Direct) Due to an administrative error, the number of securities reported as awarded to the Reporting Person on March 3, 2026 was overstated by 346 shares. This Form 4/A is being filed to report the correct number of securities awarded.	Common Stock	4,726	—	—	73,082
2026-03-03	Mendelsohn D. Eric	Director, CEO and President	Tax↓ Filing footnotes — Common Stock (Direct) Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock on March 3, 2026.	Common Stock	597	$86.75	$51,790	132,210
2026-03-03	Chapin Robert	Director	Award↑ Filing footnotes — Common Stock (Direct) Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.	Common Stock	1,268	—	—	1,268
2026-03-03	Donohue Lilly	Director	Award↑ Filing footnotes — Common Stock (Direct) Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.	Common Stock	1,268	—	—	1,268
2026-03-03	MCCABE ROBERT A JR	Director, Chief Banking Officer	Award↑ Filing footnotes — Shares Of Common Stock (Direct) Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.	Shares Of Common Stock	1,268	—	—	43,268
2026-03-03	Travis David L	SVP/Chief Accounting Officer	Award↑ Filing footnotes — Common Stock (Direct) Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to the reporting person's continued service through each vesting date.	Common Stock	3,458	—	—	41,258
2026-02-23	Travis David L	SVP/Chief Accounting Officer	Convert↓	Stock Option (Right to Buy) 2024	8,333	—	—	0
2026-02-23	PASCOE KEVIN CARLTON	Chief Investment Officer	Convert↑	Common Stock	8,500	$57.76	$490,960	74,765
2026-02-23	Travis David L	SVP/Chief Accounting Officer	Convert↓	Stock Option (Right to Buy) 2024	8,333	—	—	0
2026-02-23	Mendelsohn D. Eric	Director, CEO and President	Tax↓	Common Stock	10,192	$90.03	$917,586	118,592
2026-02-23	Mendelsohn D. Eric	Director, CEO and President	Convert↓	Stock Option (Right to Buy) 2024	13,334	—	—	0
2026-02-23	PASCOE KEVIN CARLTON	Chief Investment Officer	Convert↓	Stock Option (Right to Buy) 2024	8,500	—	—	0
2026-02-23	Travis David L	SVP/Chief Accounting Officer	Tax↓	Common Stock	19,322	$90.03	$1,739,560	37,800
2026-02-23	Travis David L	SVP/Chief Accounting Officer	Convert↑	Common Stock	8,333	$57.76	$481,314	40,455
2026-02-23	PASCOE KEVIN CARLTON	Chief Investment Officer	Tax↓	Common Stock	6,409	$90.03	$577,002	68,356
2026-02-23	Spaid John L	CFO/EVP Finance	Tax↓ Filing footnotes — Common Stock (Direct) Reflects the disposition of 236 restricted shares upon vesting on February 23, 2026 for the settlement of taxes.	Common Stock	236	$90.03	$21,247	50,633
2026-02-23	Spaid John L	CFO/EVP Finance	Convert↓	Stock Option (Right to Buy) 2024	8,500	—	—	0
2026-02-23	Spaid John L	CFO/EVP Finance	Convert↑	Common Stock	8,500	$57.76	$490,960	57,181
2026-02-23	Travis David L	SVP/Chief Accounting Officer	Convert↓	Stock Option (Right to Buy) 2024	8,334	—	—	0
2026-02-23	Mendelsohn D. Eric	Director, CEO and President	Tax↓ Filing footnotes — Common Stock (Direct) Reflects the disposition of 194 restricted shares upon vesting on February 23, 2026 for the settlement of taxes.	Common Stock	194	$90.03	$17,466	118,398
2026-02-23	Travis David L	SVP/Chief Accounting Officer	Convert↑	Common Stock	8,333	$57.76	$481,314	48,788
2026-02-23	Mendelsohn D. Eric	Director, CEO and President	Convert↑	Common Stock	13,334	$57.76	$770,172	128,784
2026-02-23	Spaid John L	CFO/EVP Finance	Tax↓	Common Stock	6,312	$90.03	$568,269	50,869
2026-02-23	Travis David L	SVP/Chief Accounting Officer	Convert↑	Common Stock	8,334	$57.76	$481,372	57,122
2026-02-19	COLDEN TRACY M J	Director	Convert↑	Common Stock	10,000	$73.34	$733,400	19,857
2026-02-19	COLDEN TRACY M J	Director	Convert↓	Stock Option (Right to Buy) 2025	10,000	—	—	0
2026-02-19	COLDEN TRACY M J	Director	Tax↓	Common Stock	8,267	$88.72	$733,448	11,590
2026-02-17	Jobe James R	Director	Convert↓	Stock Option (Right to Buy) 2025	10,000	—	—	0
2026-02-17	Mendelsohn D. Eric	Director, CEO and President	Convert↓	Stock Option (Right to Buy) 2025	25,000	—	—	0
2026-02-17	Donohue Lilly	Director	Other↑	No Securities Owned	0	—	—	0
2026-02-17	Jobe James R	Director	Convert↑	Common Stock - Jointly held with spouse	10,000	$73.34	$733,400	41,555
2026-02-17	Jobe James R	Director	Tax↓	Common Stock - Jointly held with spouse	8,058	$91.02	$733,439	33,497
2026-02-17	Mendelsohn D. Eric	Director, CEO and President	Convert↑	Common Stock	25,000	$73.34	$1,833,500	137,505
2026-02-17	Mendelsohn D. Eric	Director, CEO and President	Tax↓	Common Stock	22,055	$91.02	$2,007,446	115,450
2026-02-12	MCCABE ROBERT A JR	Director, Chief Banking Officer	Convert↑	Shares Of Common Stock	10,000	$73.34	$733,400	50,180
2026-02-12	MCCABE ROBERT A JR	Director, Chief Banking Officer	Convert↓	Stock Option (Right to Buy) 2025	10,000	—	—	0
2026-02-12	MCCABE ROBERT A JR	Director, Chief Banking Officer	Tax↓ Filing footnotes — Shares Of Common Stock (Direct) Includes 1,742.79 shares acquired in 2025 due to enrollment in Dividend Reinvestment Plan.	Shares Of Common Stock	8,180	$89.66	$733,419	42,000

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 470 transactions

Key facts CIK 877860 CUSIP 63633D104 13F (30d) 19 filings 18 filers Visit website Investor relations